FTC Clearance Of Watson’s Andrx Acquisition Requires 13 Generic Divestitures
This article was originally published in The Pink Sheet Daily
Executive Summary
Proposed consent decree calls for Watson/Andrx to sell marketing rights for generic Glucotrol XL and generic Vicoprofen.
You may also be interested in...
Watson/Actavis Merger Requires Near Record Divestiture; Sandoz, Par Pick Up 18 Products
The required divestitures are quite significant relative to the size of the transaction: this is the second-largest divesture, but only the fifth-largest merger of generic firms.
Watson Integration Of Andrx Underway With 66 Combined ANDAs Pending
With acquisition of Andrx finalized, Watson now has three business divisions: Brand, Generic and Anda distribution.
Watson Integration Of Andrx Underway With 66 Combined ANDAs Pending
With acquisition of Andrx finalized, Watson now has three business divisions: Brand, Generic and Anda distribution.